


100-200 Members of Congress, Families and Staff Treated with Ivermectin. No Hospitalizations - Global ResearchGlobal Research - Centre for Research on Globalization














































































Home
About
Contact
Membership
Store
Donate
Archives
 

USA
Canada
Latin America
Africa
Middle East
Europe
Russia
Asia
Oceania










Italiano
Deutsch
Português
srpski
العربية
中文

Notre site en Français: mondialisation.ca
Nuestro sitio en español: Globalizacion

Asia-Pacific Research



Global Research








Translate WebsiteShqipአማርኛالعربيةՀայերենAzərbaycan diliEuskaraБеларуская моваবাংলাBosanskiБългарскиCatalàCebuanoChichewa简体中文繁體中文CorsuHrvatskiČeština‎DanskNederlandsEnglishEestiFilipinoSuomiFrançaisქართულიDeutschΕλληνικάગુજરાતીKreyol ayisyenHarshen Hausaעִבְרִיתहिन्दीHmongMagyarÍslenskaIgboBahasa IndonesiaItaliano日本語Basa Jawaಕನ್ನಡҚазақ тіліភាសាខ្មែរ한국어كوردی‎КыргызчаພາສາລາວLatviešu valodaLietuvių kalbaМакедонски јазикMalagasyBahasa MelayuമലയാളംMalteseTe Reo MāoriमराठीМонголဗမာစာनेपालीNorsk bokmålپښتوفارسیPolskiPortuguêsਪੰਜਾਬੀRomânăРусскийSamoanСрпски језикSesothoShonaسنڌيසිංහලSlovenčinaSlovenščinaAfsoomaaliEspañolBasa SundaKiswahiliSvenskaТоҷикӣதமிழ்తెలుగుไทยTürkçeУкраїнськаاردوO‘zbekchaTiếng ViệtCymraegisiXhosaיידישYorùbáZulu


















grtv
youtube
twitter
facebook
rss






US Nato War
Economy
Civil Rights
Environment
Poverty
Media
Justice
9/11
War Crimes
Militarization
History
Science









100-200 Members of Congress, Families and Staff Treated with Ivermectin. No Hospitalizations
Protocol from Front Line COVID Critical Care Doctors


By Sundance
Global Research, October 13, 2021
 The Last Refuge 9 October 2021


Region: USA
Theme: Science and Medicine




       
Translate WebsiteShqipአማርኛالعربيةՀայերենAzərbaycan diliEuskaraБеларуская моваবাংলাBosanskiБългарскиCatalàCebuanoChichewa简体中文繁體中文CorsuHrvatskiČeština‎DanskNederlandsEnglishEestiFilipinoSuomiFrançaisქართულიDeutschΕλληνικάગુજરાતીKreyol ayisyenHarshen Hausaעִבְרִיתहिन्दीHmongMagyarÍslenskaIgboBahasa IndonesiaItaliano日本語Basa Jawaಕನ್ನಡҚазақ тіліភាសាខ្មែរ한국어كوردی‎КыргызчаພາສາລາວLatviešu valodaLietuvių kalbaМакедонски јазикMalagasyBahasa MelayuമലയാളംMalteseTe Reo MāoriमराठीМонголဗမာစာनेपालीNorsk bokmålپښتوفارسیPolskiPortuguêsਪੰਜਾਬੀRomânăРусскийSamoanСрпски језикSesothoShonaسنڌيසිංහලSlovenčinaSlovenščinaAfsoomaaliEspañolBasa SundaKiswahiliSvenskaТоҷикӣதமிழ்తెలుగుไทยTürkçeУкраїнськаاردوO‘zbekchaTiếng ViệtCymraegisiXhosaיידישYorùbáZulu



















All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Visit and follow us on Instagram at @crg_globalresearch.
***
 
This is beyond disturbing.  According to Dr Pierre Kory, MD, MPA, and verified by the Front Line COVID-19 Critical Care Alliance (FLCCC), 100 to 200 congressional reps and/or staff and families who contracted COVID-19 were treated with the Front Line Ivermectin protocol. [LINK and LINK]
 
This successful treatment is happening at the same time many congressional representatives are playing politics in favor of the vaccine; downplaying the effective anti-viral treatment and therapeutic approach with Ivermectin; and taking action to block regular American citizens from seeking similar treatment with Ivermectin.
Congress can seek treatment with a medication they simultaneously deny to others?  This is well beyond a “scandal”, and needs to be investigated quickly.
Additionally, as Merck has announced a new and similar anti-viral drug called Molnupiravir, two trial studies in India have requested to exit the trials.  Apparently the issue surrounds the new drug providing no benefit once a patient is moderately ill and hospitalized (READ MORE, Reuters Link).
Dr. John Campbell highlights a comparison between Ivermectin and Molnupiravir below:

*
Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.
Featured image is from Zero Hedge

The original source of this article is The Last Refuge
Copyright © Sundance, The Last Refuge, 2021


Comment on Global Research Articles on our Facebook page


Become a Member of Global Research

 




Related Articles from our Archives
 



       
Translate WebsiteShqipአማርኛالعربيةՀայերենAzərbaycan diliEuskaraБеларуская моваবাংলাBosanskiБългарскиCatalàCebuanoChichewa简体中文繁體中文CorsuHrvatskiČeština‎DanskNederlandsEnglishEestiFilipinoSuomiFrançaisქართულიDeutschΕλληνικάગુજરાતીKreyol ayisyenHarshen Hausaעִבְרִיתहिन्दीHmongMagyarÍslenskaIgboBahasa IndonesiaItaliano日本語Basa Jawaಕನ್ನಡҚазақ тіліភាសាខ្មែរ한국어كوردی‎КыргызчаພາສາລາວLatviešu valodaLietuvių kalbaМакедонски јазикMalagasyBahasa MelayuമലയാളംMalteseTe Reo MāoriमराठीМонголဗမာစာनेपालीNorsk bokmålپښتوفارسیPolskiPortuguêsਪੰਜਾਬੀRomânăРусскийSamoanСрпски језикSesothoShonaسنڌيසිංහලSlovenčinaSlovenščinaAfsoomaaliEspañolBasa SundaKiswahiliSvenskaТоҷикӣதமிழ்తెలుగుไทยTürkçeУкраїнськаاردوO‘zbekchaTiếng ViệtCymraegisiXhosaיידישYorùbáZulu
















Articles by:
Sundance 



Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
copyright owner.
For media inquiries: [email protected]









Global Research News
I-BOOKS SERIES
Countries Index
Most Popular
Links
Contact
Membership
Online Store
 



Themes
Geographic Regions

US NATO War Agenda
Global Economy
Crimes against Humanity
Militarization and WMD
Law and Justice
Police State & Civil Rights
History
9/11 & ‘War on Terrorism’
Media Disinformation
Militarization and WMD
Oil and Energy
Police State & Civil Rights
Religion
Poverty & Social Inequality
Science and Medicine
United Nations
US NATO War Agenda
Women’s Rights
 

GlobalResearch Center for Research on Globalization
Privacy Policy
Copyright © 2005-2023 GlobalResearch.ca













Become Member of
Global Research
 Free Books!
Become a member



× 














